Rapid Refill Continuous Injection System, UPN M00566001 Recall
Issued July 22, 2026 · Boston Scientific Corporation
In July 2026, Boston Scientific Corporation recalled the Rapid Refill Continuous Injection System, UPN M00566001, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete disconnection. May lead to difficulty connecting syringe, inability to aspirate or inject properly, fluid leakage, or separation of the syringe from the system, potentially requiring device exchange and prolonging the procedure.
What you should do
- 1 Stop using Rapid Refill Continuous Injection System, UPN M00566001 right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Boston Scientific Corporation to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Recall details
- Brand
- Boston Scientific Corporation
- Category
- Health
- Recall date
- July 22, 2026
- Units affected
- Not reported
- Sold at
- US Nationwide distribution. OUS consignee list pending.
- Recall number
- FDA-Z-2725-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Boston Scientific Corporation has 37 recalls in our database, including 13 rated Critical.
- We're tracking 3,673 Health recalls in our database.
- This is the 453rd Health recall we've logged in 2026.